A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
for Metastatic Castration-Resistant Prostate Cancer
Sites in San Diego, Palo Alto +10 more locations
Sponsor: AstraZeneca
Sex: Male·Age: 18+
Code: NCT06879041·Phase 1·Recruiting·Listed Mar 2025